Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-011843
Filing Date
2025-02-12
Accepted
2025-02-12 08:00:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6648
  Complete submission text file 0001104659-25-011843.txt   8364
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Subject) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-52381 | Film No.: 25612046
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2609 CALDWELL MILL LN BIRMINGHAM AL 35243
Business Address
SATTERFIELD THOMAS A JR (Filed by) CIK: 0001132317 (see all company filings)

Type: SCHEDULE 13G/A